Vascular endothelial growth factor in primate endometrium is regulated by oestrogen-receptor and progesterone-receptor ligands in vivo

Human Reproduction

Volumn 12, Issue 6, 1997, Pages 1280-1292

  Greb, R R ^a,b   Heikinheimo, O ^a,c   Williams, R F ^a   Hodgen, G D ^a   Goodman, A L ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Angiogenesis; Endometrium; Mifepristone; Ovarian steroids; Vascular endothelial growth factor

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR; GESTAGEN; ISOPROTEIN; LEVONORGESTREL; MIFEPRISTONE; PROGESTERONE RECEPTOR; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOMETRIUM; FEMALE; GENE EXPRESSION; HORMONAL REGULATION; LUTEAL PHASE; NONHUMAN; OVARIECTOMY; PRIMATE;

ANIMALIA; MACACA FASCICULARIS; PRIMATES;

EID: 0031005638     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/12.6.1280     Document Type: Article

References (64)

1. Ace, C.I. and Okulicz, W.C. (1995) Differential gene regulation by estrogen and progesterone in the primate endometrium. Mol. Cell. Endocrinol., 115, 95-103.
2. Alon, T., Hemo, I., Itin, A. et al. (1995) Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nature Med., 1, 1024-1028.
3. Asano, M., Yukita, A., Matsumoto, T. et al. (1995) Inhibition of tumor growth and metastasis by an immunoneutralizing monoclonal antibody to human vascular endothelial growth factor vascular permeability factor (121). Cancer Res., 55, 5296-5301.
4. Battegay, E.J. (1995) Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects. J. Mol. Med., 73, 333-346.
5. Barleon, B., Hauser, S., Schöllmann, C. et al. (1994) Differential expression of the two VEGF receptors fit and KDR in placenta and vascular endothelial cells. J. Cell. Biochem., 54, 56-66.
6. Breier, G., Albrecht, U., Sterrer, S. et al. (1992) Expression of vascular endothelial growth factor duing embryonic angiogenesis and endothelial cell differentiation. Development, 114, 521-532.
7. Brenner, R.M. and Slayden, O.D. (1994) Oestrogen action in the endometrium and oviduct of rhesus monkeys during RU486 treatment. Hum. Reprod., 9 (Suppl. 1), 82-97.
8. Bruner, K.L., Rodgers, W.H., Gold, L.I. et al. (1995) Transforming growth factor beta mediates the progesterone suppression of an epithelial metalloproteinase by adjacent stroma in the human endometrium. Proc. Natl. Acad. Sci. USA, 92, 7362-7366.
9. Cameron, S.T., Critchley, H.O.D., Thong, K.J. et al. (1996) Effects of daily low dose mifepristone on endometrial maturation and proliferation. Hum. Reprod., 11, 2518-2526.
10. Cochran, W.G. and Bliss, C.I. (1967) Analysis of variance. In McArthur, J.W. and Colton T. (eds), Statistics in Endocrinology. MIT Press, Cambridge, MA, pp. 34-76.
11. Charnock-Jones, D.S., Sharkey, A.M., Rajput-Williams, J. et al. (1993) Identification and localization of alternately spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines. Biol. Reprod., 48, 1120-1128.
12. Charnock-Jones, D.S., Sharkey, A.M., Boocock, C.A. et al. (1994) Vascular endothelial growth factor receptor localization and activation in human trophoblast and choriocarcinoma cells. Biol. Reprod., 51, 524-530.
13. Ferenczy, A., Bertrand, G. and Gelfand, M.M. (1979) Proliferation kinetics of human endometrium during the normal menstrual cycle. Am. J Obstet. Gynecol, 133, 859-867.
14. Ferrara, N. (1993) Vascular endothelial growth factor. Trends Cardiovasc. Med., 3, 244-250.
15. Ferrara, N., Houck, K., Jakeman, L. et al. (1992) Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr. Rev., 13, 18-32.
16. Folkman, J. (1995a) Angiogenesis inhibitors generated by tumors. Mol. Med., 1, 120-122.
17. Folkman, J. (1995b) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med., 1, 27-31.
18. Goodger (Macpherson), A.M., Affandi, B. and Rogers, P.A.W. (1994) Endometrial endothelial cell proliferation in longterm users of subdermal levonorgestrel. Hum. Reprod., 9, 1647-1651.
19. Goodman, A.L., Descalzi, C.D., Johnson, D.K. and Hodgen, G.D. (1977) Composite pattern of LH, FSH, estradiol, and progesterone during the menstrual cycle in cynomolgus monkeys. Proc. Soc. Exp. Biol. Med., 155, 479-181.
20. Gordon, J.D., Shifren, J.L., Foulk, R.A. et al. (1995) Angiogenesis in the human female reproductive tract. Obstet. Gynecol. Surv., 50, 688-697.
21. Greb, R.R., Bukowski, R., Hsiu, J.G. et al. (1995) Vascular endothelial growth factor (VEGF) in primate endometrium. Immunohistochemical patterns during the cycle and after chronic RU 486 treatment in cynomolgus monkeys. Ann. NY Acad. Sci., 761, 376-382.
22. Hatva, E., Kaipainen, A., Mentula, P. et al. (1995) Expression of endothelial cell-specific receptor tyrosine kinases and growth factors in human brain tumors. Am. J. Pathol., 146, 368-78.
23. Hodgen, G.D. (1983) Surrogate embryo transfer combined with estrogen-progesterone therapy in monkeys. Implantation, gestation, and delivery without ovaries. J. Am. Med. Assoc., 250, 2167-2171.
24. Hodgen, G.D., van Uem, J.F.H.M., Chillik, C.F. et al. (1994) Non-competitive anti-oestrogenic activity of progesterone antagonists in primate models. Hum. Reprod., 9 (Suppl. 1), 77-81.
25. Holmgren, L., Oreilly, M.S. and Folkman, J. (1995) Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nature Med., 1, 149-153.
26. Houck, K.A., Ferrara, N., Winer, J. et al. (1991) The vascular endothelial growth factor family: Identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol. Endocrinol., 5, 1806-1814.
27. Houck, K.A., Leung, D.W., Rowland, A.M. et al. (1992) Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J. Biol. Chem., 267, 26031-26037.
28. Kaiserman-Abramof, I.R. and Padykula, H.A. (1989) Angiogenesis in the postovulatory primate endometrium: the coiled arteriolar system. Anat. Rec., 224, 479-489.
29. Keck, P.J., Hauser, S.D., Krivi, G. et al. (1989) Vascular permeability factor an endothelial cell mitogen related to PDGF. Science, 246, 1309-1312.
30. Kim, K.J., Li, B., Winer, J. et al. (1993) Inhibition of vascular endothelial growth factor induced angiogenesis suppresses tumour growth in vivo. Nature, 362, 841-844.
31. Kolch, W., Martinybaron, G., Kieser, A. and Marme, D. (1995) Regulation of the expression of the vegf/vps and its receptors: role in tumor angiogenesis. Breast Cancer Res. Treat., 36, 139-155.
32. Kondo, S., Asano, M. and Suzuki, H. (1993) Significance of vascular endothelial growth factor/vascular permeability factor for solid tumor growth, and its inhibition by the antibody. Biochem. Biophys. Res. Commun., 194, 1234-1241.
33. Leung, D.W., Cachianes, G., Kuang, W.J. et al (1989) Vascular endothelial growth factor is a secreted angiogenic mitogen. Science, 246, 1306-1309.
34. Li, X.F., Gregory, J. and Ahmed, A. (1994) Immunolocalisation of vascular endothelial growth factor in human endometrium. Growth Factors, 11, 277-282.
35. Marbaix, E., Kokorine, I., Henriet, P. et al. (1995) The expression of intersititial collagenase in human endometrium is controlled by progesterone and by oestradiol and is related to menstruation. Biochem. J., 305, 1027-1030.
36. Markee, J.E. (1940) Menstruation in intraocular endometrial transplants in the rhesus monkey. Contr. Embryol. Carnegie Inst., 177, 219-308.
37. Murphy, A.A., Kettel, L.M., Morales, A.J. et al. (1995) Endometrial effects of long-term low-dose administration of RU486. Fertil. Steril., 63, 761-766.
38. 3H-thymidine uptake by human endometrial and endoslpinx cells in vitro. Arch. Gynecol., 240, 225-232.
39. Neulen, J., Williams, R.F. and Hodgen, G.D. (1990) RU 486 (mifepristone): induction of dose-dependent elevations of estradiol receptor in endometrium from ovariectomized monkeys. J. Clin. Endocrinol. Metab., 71, 1074-1075.
40. Neulen, J., Williams, R.F., Breckwoldt, M. et al. (1996) Non-competitive anti-oestrogenic actions of progesterone antagonists in primate endometrium: enhancement of oestrogen and progesterone receptors with blockade of post-receptor proliferative mechanisms. Hum. Reprod., 11, 1533-1537.
41. O'Reilly, M.S., Holmgren, L., Shing, Y. et al (1994) Angiostatin: A circulating endothelial cell inhibitor that suppresses angiogenesis and tumor growth. Cold Spring Harbor Symp. Quant. Biol., 59, 471-482.
42. Park, J.E., Keller, G.A. and Ferrara, N. (1993) The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol. Biol. Cell., 4, 1317-1326.
43. Pepper, M.S., Ferrara, N., Orci, L. and Montesano, R. (1991) Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor type 1 in microvascular endothelial cells. Biochem. Biophys. Res. Commun., 181, 902-908.
44. Plate, K.H., Breier, G., Welch, H.A. and Risau, W. (1992) Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature, 359, 845-848.
45. Ponte, P., Ng, S., Engel, J. et al. (1984) Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human betaactin cDNA. Nucleic Acids Res., 12, 1687-1696.
46. Rastinejad, F., Poverini, P.J. and Bouck, N.P. (1989) Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell, 56, 345-355.
47. Rogers, P.A.W., Abberton, K.M. and Susil, B. (1992) Endothelial cell migratory signal produced by human endometrium during the menstrual cycle. Hum. Reprod., 7, 1061-1066.
48. Rogers, P.A.W., Au, C.L. and Affandi, B. (1993) Endometrial microvascular density during the normal menstrual cycle and folowing exposure to long-term levonorgestrel. Hum. Reprod., 8, 1396-1404.
49. Rone, J.D. and Goodman, A.L. (1987) Heterogeneity of rabbit aortic endothelial cells in primary culture. Proc. Soc. Exp. Biol. Med., 184, 495-503.
50. Schatz, F., Papp, C., Toth-Pal, E. and Lockwood, C.J. (1994) Ovarian steroid-modulated stromelysin-1 expression in human endometrial stromal and decidual cells. J. Clin. Endocrinol. Metab., 78, 1467-1472.
51. Senger, D.R., van de Water, L., Brown, L.F. et al. (1993) Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev., 12, 303-324.
52. Shifren, J.L., Doldi, N., Ferrara, N. et al. (1994) In the human fetus, vascular endothelial growth factor is expressed in epithelial cells and myocytes, but not vascular endothelium: implications for mode of action. J. Clin. Endocrinol. Metabol., 79, 316-322.
53. Slayden, O.D. and Brenner, R.M. (1994) RU486 action after estrogen-priming in the endometrium and oviducts of rhesus monkeys (Macaco mulatto). J. Clin. Endocrinol. Metab., 78, 440-448.
54. Smith, S.K. (1994) Growth factors in the human endometrium. Hum. Reprod. Update, 9, 936-946.
55. Sternberg, S.S. (ed.) (1992) The endometrium. Histology for Pathologists. Raven Press, New York, pp. 810-825.
56. Subakir, S.B., Hadisaputra, W., Siregar, B. et al. (1995) Reduced endothelial cell migratory signal production by endometrial explants from women using Norplant contraception. Hum. Reprod., 10, 2579-2583.
57. Tabibzadeh S. (1994) Cytokines and the hypothalamic-pituitary-ovarian-endometrial axis. Hum. Reprod., 9, 947-967.
58. Tokunaga, K., Taniguchi, H., Yoda, K. et al. (1986) Nucleotide sequence of a full-length cDNA for mouse cytoskeletal β-actin mRNA. Nucleic Acids Res., 14, 2829.
59. Thieme, H., Aiello, L.P., Takagi, H. et al. (1995) Comparative analysis of vascular endothelial growth factor receptors on retinal and aortic vascular endothelial cells. Diabetes, 44, 98-103.
60. Tischer, E., Mitchell, R., Harman, T. et al. (1991) The human gene for vascular endothelial growth factor. J. Biol. Chem., 266, 11947-11954.
61. Tokunaga, K., Taniguchi, H., Yoda, K. et al. (1986) Nucleotide sequence of a full-length cDNA for mouse cytoskeletal b-actin mRNA. Nucleic Acids Res., 14, 2829.
62. Warren, R.S., Yuan, H., Matli, M.R. et al (1995) Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J. Clin. Invest., 95, 1789-1797.
63. Williams, R:F., Chwalisz, K., Kim, S. et al. (1994) Intermittent antiprogestin reduces unscheduled (breakthrough) bleeding during estrogen-progestin hormonal therapy in ovariectomized monkeys. 41st Annual Meeting of the Society for Gynecologic Investigation, Chicago, March 22-26, Abstract P8.
64. Wolf, J.P., Hsiu, J.G, Anderson, T.L. et al. (1989) Noncompetitive antiestrogenic effect of RU 486 in blocking the estrogen-stimulated luteinizing hormone surge and the proliferative action of estradiol on endometrium in castrate monkeys. Fertil. Steril, 52, 1055-1060.